Hou Ping, Liu Guiying, Zhao Yingjun, Shi Zhun, Zheng Qiuyang, Bu Guojun, Xu Huaxi, Zhang Yun-wu
Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, College of Medicine, Xiamen University, Xiamen, China; School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.
Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, College of Medicine, Xiamen University, Xiamen, China.
Neurobiol Aging. 2015 Mar;36(3):1310-5. doi: 10.1016/j.neurobiolaging.2014.12.005. Epub 2014 Dec 11.
One major pathologic hallmark and trigger of Alzheimer's disease (AD) is overproduction and accumulation of β-amyloid (Aβ) species in the brain. Aβ is derived from β-amyloid precursor protein (APP) through sequential cleavages by β- and γ-secretases. Abnormal copper homeostasis also contributes to AD pathogenesis. Recently, we find that a copper-related protein, CutA divalent cation tolerance homolog of Escherichia coli (CUTA), interacts with the β-secretase β-site APP cleaving enzyme 1 (BACE1) and inhibits APP β-processing and Aβ generation. Herein, we further found that overexpression of CUTA increases intracellular copper level, whereas copper treatments promote CUTA expression. We also confirmed that copper treatments promote APP expression and Aβ secretion. In addition, copper treatments promoted the increase of Aβ secretion induced by CUTA downregulation but had no effect on CUTA-β-site APP cleaving enzyme 1 interaction. On the other hand, CUTA overexpression ameliorated copper-induced Aβ secretion but had no effect on APP expression. Moreover, we found that Aβ treatments can reduce both CUTA and copper levels in mouse primary neurons. Consistently, both CUTA and copper levels were decreased in the hippocampus of APP/PS1 AD mouse brain. Together, our results reveal a reciprocal modulation of copper and CUTA and suggest that both regulate Aβ generation through different mechanisms, although Aβ mutually affects copper and CUTA levels.
阿尔茨海默病(AD)的一个主要病理标志和触发因素是大脑中β-淀粉样蛋白(Aβ)的过度产生和积累。Aβ是由β-淀粉样前体蛋白(APP)通过β-和γ-分泌酶的顺序切割产生的。异常的铜稳态也与AD发病机制有关。最近,我们发现一种与铜相关的蛋白,大肠杆菌二价阳离子耐受性同源物CutA(CUTA),与β-分泌酶β位点APP切割酶1(BACE1)相互作用,并抑制APP的β加工和Aβ生成。在此,我们进一步发现CUTA的过表达会增加细胞内铜水平,而铜处理会促进CUTA表达。我们还证实铜处理会促进APP表达和Aβ分泌。此外,铜处理促进了CUTA下调诱导Aβ分泌的增加,但对CUTA与β位点APP切割酶1的相互作用没有影响。另一方面,CUTA过表达减轻了铜诱导的Aβ分泌,但对APP表达没有影响。此外,我们发现Aβ处理可降低小鼠原代神经元中的CUTA和铜水平。一致地,在APP/PS1 AD小鼠脑的海马体中,CUTA和铜水平均降低。总之,我们的结果揭示了铜和CUTA的相互调节,并表明两者通过不同机制调节Aβ生成,尽管Aβ会相互影响铜和CUTA水平。